Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-34256

 

 

HeartWare International, Inc.

(Exact name of registrant as specified in its charter)

 

 

c/o Medtronic, Inc.

710 Medtronic Parkway

Minneapolis, Minnesota 55432

(763)-514-4000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

3.50% Convertible Senior Notes due 2017

(Title of each class of securities covered by this Form)

Common Stock, $0.001 par value per share

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)		¨
Rule 12g-4(a)(2)		¨
Rule 12h-3(b)(1)(i)		x
Rule 12h-3(b)(1)(ii)		¨
Rule 15d-6		¨
Rule 15d-22(b)		¨

Approximate number of holders of record as of the certification or notice date:                     

3.50% Convertible Senior Notes due 2017: Less than 300

Pursuant to the requirements of the Securities Exchange Act of 1934, HeartWare International, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

				HEARTWARE INTERNATIONAL, INC.
Date: August 23, 2016				By:		/s/ Philip J. Albert
				Name: Philip J. Albert
				Title: Vice President